Effect of one or two cycles of dual immunotherapy with nivolumab and ipilimumab in patients with mismatch repair-deficient rectal cancer (RESET-R): interim results from a multicentre, single-arm, phase 2 trial

Authors:

Abstract
No abstract available
Funding Information
  • Øjenfonden
  • Eva og Henry Frænkels Mindefond
  • Aage og Johanne Louis-Hansens Fond

This publication has 27 references indexed in Scilit: